Biotech · Private company · Bethesda, MD, US
Technical Resources International, Inc.
Track this companyFree. Adds Technical Resources International, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials1
- Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic FeverPHASE1 · RECRUITING · started Jul 10, 2025ClinicalTrials.gov NCT06799013 · fetched Nov 12, 2026
NIH awards10
- IPP - DRUG DEVELOPMENT SUPPORT FOR CTEPFiscal year 2026 · $8.2MNIH RePORTER 75N91022C00014-P00008-9999-1 · fetched Nov 12, 2026
- TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU.Fiscal year 2026 · $836.1KNIH RePORTER 75N91022D00014-P00008-759102200001-2 · fetched Nov 12, 2026
- DAIDS Quality Assurance, Quality Control and Inspection Readiness Support ServicesFiscal year 2026 · $3MNIH RePORTER 75N93021D00038-P00001-759302500001-1 · fetched Nov 12, 2026
- NIAID/Division of AIDS: Regulatory Support CenterFiscal year 2026 · $18.7MNIH RePORTER 75N93021D00038-P00006-759302400001-1 · fetched Nov 12, 2026
- Regulatory Affairs SupportFiscal year 2026 · $3.7MNIH RePORTER 75N93022C00010-P00007-9999-1 · fetched Nov 12, 2026
- Preclinical and Translational Vaccine Development Support for HIV and Other Candidate Agents: Scientific, Quality and Regulatory Support ServicesFiscal year 2026 · $190KNIH RePORTER 75N93022D00008-P00005-759302200001-1 · fetched Nov 12, 2026
- DMID Clinical Research Operations & Management Support (CROMS)Fiscal year 2026 · $23.6MNIH RePORTER 75N93024C00004-P00004-9999-1 · fetched Nov 12, 2026
- TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).Fiscal year 2026 · $11.4KNIH RePORTER 75N95025D00007-0-759802600001-1 · fetched Nov 12, 2026
- PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2028. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).Fiscal year 2026 · $45.4KNIH RePORTER 75N95025D00007-P00001-759502500001-2 · fetched Nov 12, 2026
- IPP - DRUG DEVELOPMENT SUPPORT FOR CTEPFiscal year 2025 · $8MNIH RePORTER 75N91022C00014-P00005-9999-1 · fetched Nov 12, 2026